MEDP

Q: What is the price of Medpace Holdings (MEDP) today?

The price of Medpace Holdings (MEDP) today is $ 470.59, with return of 44.47% compared to the last year. The price of Medpace Holdings (MEDP) started the year trading around $ 561.65 and today it is at $ 470.59. Follow the real-time price chart, the historical price of Medpace Holdings (MEDP) and international markets.

Q: When does Medpace Holdings (MEDP) pay dividends?

Medpace Holdings (MEDP) did not distribute dividends in the last year.

Q: Is Medpace Holdings (MEDP) worth it?

Currently, Medpace Holdings (MEDP) is priced at $ 470.59, with a P/E of 28.04%, representing a deviation of 2,904% from its historical average P/E. In the last year, the stock showed a variation of 44.47 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 44.47%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Medpace Holdings (MEDP) stock?

Investing in stocks of Medpace Holdings (MEDP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Medpace Holdings (MEDP) yield today?

The yield of Medpace Holdings (MEDP) was -16.19% in the last month, 44.47% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Medpace Holdings (MEDP) today, the total investment would be $ 47,059.00, based on the current price of $ 470.59.If past performance were to repeat, the return on your investment would be:In 1 year: $ 67,986.14In 5 years: $ 47,059.00In 10 years: $ 47,059.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Medpace Holdings Inc.

Price

$ 470.59

return (12m)

44.47%

p/e

28.04

p/b

27.55

DIVIDEND YIELD

0.00%

price MEDP

MEDP

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment MEDP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-16.19%

3 months

-14.14%

1 year

44.47%

2 years

14.74%

5 years

0.00%

10 years

0.00%

Fundamentals MEDP

review the fundamentals of Medpace Holdings shares

P/E

28.04

Sector: -3.72 Industry: -3.72

P/S (Price-to-Sales)

5.00

Sector: -3.84 Industry: -3.84

P/B

27.55

Sector: 1.99 Industry: 1.99

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

22.84%

Sector: -64.61% Industry: -64.61%

ROE

98.27%

Sector: -66.34% Industry: -66.34%

ROIC

26.67%

Sector: -1,293.53% Industry: -1,293.53%

NET MARGIN

17.83%

Sector: -40.94% Industry: -40.94%

GROSS MARGIN

30.06%

Sector: 39.00% Industry: 39.00%

OPERATING MARGIN

21.14%

Sector: -40.81% Industry: -40.81%

EV/EBITDA

22.47

Sector: -3.76 Industry: -3.76

EV/EBIT

23.65

Sector: -3.91 Industry: -3.91

PRICE-TO-ASSETS

6.40

Sector: 1.45 Industry: 1.45

BVPS

16.40

Sector: 1.76 Industry: 1.76

EPS

16.11

Sector: -2.03 Industry: -2.03

EQUITY-TO-ASSETS RATIO

0.23

Sector: 0.40 Industry: 0.40

LIABILITIES / ASSETS

0.77

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

17.24%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

19.94%

Sector: - Industry: -

FAIR VALUE OF Medpace Holdings ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 470.59

Fair Value

$ 0.00

Upside Return potential.

-83.62%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals MEDP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
JNJ	22.33	7.55	33.81%	2.07%	$ 598.47 B	28.46%
PFE	20.23	1.69	8.35%	6.22%	$ 157.22 B	12.42%
ABBV	97.04	0.00	0.00%	2.87%	$ 410.09 B	6.91%
NVO	10.62	5.47	51.50%	4.51%	$ 166.32 B	33.05%
MRK	16.84	0.00	0.00%	2.65%	$ 307.32 B	28.08%
AZN	30.28	6.35	20.99%	1.57%	$ 309.60 B	17.41%
GILD	21.74	8.18	37.62%	2.12%	$ 185.00 B	28.90%
BMY	18.00	-3.73	-20.72%	3.99%	$ 126.99 B	14.64%
ZTS	21.48	17.24	80.25%	1.53%	$ 57.42 B	28.23%
REGN	17.87	2.58	14.41%	0.45%	$ 80.51 B	31.41%
HALO	25.89	168.09	649.21%	0.00%	$ 8.20 B	22.69%
AMGN	27.13	24.16	89.06%	2.45%	$ 209.22 B	20.98%
MCK	27.98	-1,226.73	-4,383.84%	0.31%	$ 121.45 B	1.09%
VRTX	31.92	6.76	21.18%	0.00%	$ 126.19 B	32.94%
CAH	32.55	-20.04	-61.56%	0.89%	$ 54.10 B	0.68%
ADMA	17.77	8.63	48.57%	0.00%	$ 3.72 B	42.87%
BIIB	21.81	1.54	7.08%	0.00%	$ 28.20 B	13.07%
HRMY	8.91	1.98	22.24%	0.00%	$ 1.66 B	22.48%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

MEDP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Medpace Holdings

Medpace Holdings Inc.

Average user rating I10

4.0 (14 people)

United States

12 years

Founded: 2014

2016

Time since IPO - 10 years

3.500

Employees

The Company Medpace Holdings Inc. (United States), is listed on Nasdaq with a market value of $ 12.65 Billions, having an equity of $ 459.07 Millions.

With a total of 3.500 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 2.53 Billions, which generated a profit in the amount of $ 451.12 Millions.

As for its main indicators, the Company has a P/E ratio of 28.04, a P/BV ratio of 27.55 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker MEDP.

Market cap

$ 12.65 Billions

Net worth

$ 459.07 Millions

US$ 459,070,000.00

Assets

$ 1.98 Billion

US$ 1,975,470,000.00

Total Shares Outstanding

28.00 Millions

28,000,000

Average Daily Trading Volume

$ 323.11 Thousand

US$ 323,106.34

Sector

Health Care

Industry

Biotechnology

MEDP

MEDP revenue and profits

Financial Results MEDP

DRAG THE FRAME TO SEE MORE DATA

MEDP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/B

0.00

MCK - McKesson

$ 919.26 43,42% (12M)

P/E

27.98

0.31%

ROE

-4,383.84%

P/B

-1,226.73

CAH - Cardinal Health

$ 217.78 74,71% (12M)

P/E

32.55

0.89%

ROE

-61.56%

P/B

-20.04

JNJ - Johnson & Johnson

$ 240.40 48,24% (12M)

P/E

22.33

2.07%

ROE

33.81%

P/B

7.55

PFE - Pfizer

$ 27.05 8,54% (12M)

P/E

20.23

6.22%

ROE

8.35%

P/B

1.69

ABBV - AbbVie

$ 230.11 11,82% (12M)

P/E

97.04

2.87%

ROE

0.00%

P/B

0.00

MRK - Merck & Co.

$ 115.79 27,82% (12M)

P/E

16.84

2.65%

ROE

0.00%

P/B

0.00

AZN - AstraZeneca

$ 194.22 31,94% (12M)

P/E

30.28

1.57%

ROE

20.99%

P/B

6.35

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 919.26 43,42% (12 M)

P/L

27.98

0.31%

ROE

-4,383.84%

P/VP

-1,226.73

CAH - Cardinal Health

$ 217.78 74,71% (12 M)

P/L

32.55

0.89%

ROE

-61.56%

P/VP

-20.04

JNJ - Johnson & Johnson

$ 240.40 48,24% (12 M)

P/L

22.33

2.07%

ROE

33.81%

P/VP

7.55

PFE - Pfizer

$ 27.05 8,54% (12 M)

P/L

20.23

6.22%

ROE

8.35%

P/VP

1.69

ABBV - AbbVie

$ 230.11 11,82% (12 M)

P/L

97.04

2.87%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 115.79 27,82% (12 M)

P/L

16.84

2.65%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 194.22 31,94% (12 M)

P/L

30.28

1.57%

ROE

20.99%

P/VP

6.35

Frequently Asked Questions

What is the price of Medpace Holdings (MEDP) today?

The price of Medpace Holdings (MEDP) today is $ 470.59, with return of 44.47% compared to the last year. The price of Medpace Holdings (MEDP) started the year trading around $ 561.65 and today it is at $ 470.59. Follow the real-time price chart, the historical price of Medpace Holdings (MEDP) and international markets.

When does Medpace Holdings (MEDP) pay dividends?

Medpace Holdings (MEDP) did not distribute dividends in the last year.

Is Medpace Holdings (MEDP) worth it?

Currently, Medpace Holdings (MEDP) is priced at $ 470.59, with a P/E of 28.04%, representing a deviation of 2,904% from its historical average P/E. In the last year, the stock showed a variation of 44.47 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 44.47%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Medpace Holdings (MEDP) stock?

Investing in stocks of Medpace Holdings (MEDP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Medpace Holdings (MEDP) yield today?

The yield of Medpace Holdings (MEDP) was -16.19% in the last month, 44.47% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Medpace Holdings (MEDP) today, the total investment would be $ 47,059.00, based on the current price of $ 470.59.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 67,986.14
In 5 years: $ 47,059.00
In 10 years: $ 47,059.00

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

MEDP

Medpace Holdings Inc.

Price

return (12m)

p/e

p/b

DIVIDEND YIELD

Return on Investment MEDP

review the fundamentals of Medpace Holdings shares

P/E

P/S (Price-to-Sales)

P/B

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Medpace Holdings

Medpace Holdings Inc.

United States

12 years

2016

3.500

PROFIT X PRICE MEDP

Financial Results MEDP

MEDP cash flow

asset growth - MEDP

MEDP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions